Scientific article

Dépistage du cancer de la prostate: actualité

Published inRevue médicale suisse, vol. 5, no. 228, p. 2438-2441
Publication date2009

Prostate cancer screening using PSA is controversial because of a low specificity and detection of non clinically relevant cancer. Two important studies have been published recently. One of two studies suggests a 20% lowering in specific prostate cancer mortality due to PSA screening. This benefit is relevant but implies at a high risk of overtreatment and treatment-related complications. Currently PSA screening is only proposed as an individual screening for informed patients.

  • Humans
  • Male
  • Prostate-Specific Antigen/blood
  • Prostatic Neoplasms/blood/diagnosis
Citation (ISO format)
TAWADROS, T et al. Dépistage du cancer de la prostate: actualité. In: Revue médicale suisse, 2009, vol. 5, n° 228, p. 2438–2441.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation10/31/2013 3:55:00 PM
First validation10/31/2013 3:55:00 PM
Update time03/14/2023 8:45:13 PM
Status update03/14/2023 8:45:13 PM
Last indexation08/29/2023 8:21:50 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack